Related Experiment Video
Updated: Jul 2, 2025
06:40
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
3.3K
New-Onset Illness Anxiety Disorder After Helicobacter Pylori Infection: A Case Report
Suhail A Labban1, Leen Murshid2, Amal Yousef Alhazmi1
1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Cureus
|February 20, 2024
Summary
A young woman developed new-onset illness anxiety disorder (IAD) following Helicobacter pylori infection. This case highlights the link between H. pylori and IAD, exploring treatment options.
Area of Science:
- Psychiatry
- Infectious Diseases
- Gastroenterology
Background:
- Illness anxiety disorder (IAD) is characterized by persistent health-related anxiety.
- Helicobacter pylori infection is a common gastrointestinal pathogen.
- The potential link between H. pylori infection and psychiatric disorders is an emerging area of research.
Observation:
- A 21-year-old female presented with new-onset IAD after a confirmed H. pylori infection.
- Her symptoms included excessive preoccupation with illness and mild somatic complaints for over six months.
- The patient exhibited significant distress, excessive healthcare seeking, and avoidance behaviors.
Findings:
- This case demonstrates a unique presentation of IAD potentially triggered by H. pylori infection.
- Psychosocial factors may contribute to the development of IAD in the context of infection.
- The study underscores the importance of considering gastrointestinal infections in the differential diagnosis of IAD.
Implications:
- Recognizing the association between H. pylori and IAD can lead to earlier diagnosis and intervention.
- Integrated treatment approaches combining pharmacological and psychological therapies may be beneficial.
- Further research is warranted to elucidate the pathophysiology and prevalence of H. pylori-associated IAD.
More Related Videos
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
403
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
119
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
119
01:23Gastritis III: Clinical Manifestations and Management
248
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
248
01:30Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
591
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
591
01:26Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92